Abstract
In 2008, the combined U.S. market for dental bone graft substitutes and other
biomaterials was valued at just under $200 million. This market includes bone
graft substitutes, tissue engineering products, and dental membranes. The
market is expected to grow rapidly as the number of bone graft procedures
associated with dental implants rises.
|